These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34313784)

  • 21. Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
    Kawase A; Inoue Y; Nakazaki S; Koizumi E; Iwaki M
    Oncol Rep; 2019 Jul; 42(1):283-290. PubMed ID: 31115547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells.
    Tomono T; Yano K; Ogihara T
    J Pharm Sci; 2017 Sep; 106(9):2642-2649. PubMed ID: 28322937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.
    Adyshev DM; Moldobaeva NK; Elangovan VR; Garcia JG; Dudek SM
    Cell Signal; 2011 Dec; 23(12):2086-96. PubMed ID: 21864676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-resistance conferred by altered expression of efflux and influx transporters for paclitaxel in the human hepatoma cell line, HepG2.
    Takano M; Otani Y; Tanda M; Kawami M; Nagai J; Yumoto R
    Drug Metab Pharmacokinet; 2009; 24(5):418-27. PubMed ID: 19881253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osmotic cell shrinkage activates ezrin/radixin/moesin (ERM) proteins: activation mechanisms and physiological implications.
    Rasmussen M; Alexander RT; Darborg BV; Møbjerg N; Hoffmann EK; Kapus A; Pedersen SF
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C197-212. PubMed ID: 17977945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
    BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Alterations of Multidrug Resistance-Associated Proteins 2 and 5, and Breast Cancer Resistance Protein upon Snail-Induced Epithelial-Mesenchymal Transition in HCC827 Cells.
    Yano K; Todokoro I; Kamioka H; Tomono T; Ogihara T
    Biol Pharm Bull; 2021; 44(1):103-111. PubMed ID: 33390536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation.
    Jung HY; Fattet L; Tsai JH; Kajimoto T; Chang Q; Newton AC; Yang J
    Nat Cell Biol; 2019 Mar; 21(3):359-371. PubMed ID: 30804505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slug Mediates MRP2 Expression in Non-Small Cell Lung Cancer Cells.
    Zhang X; Liu W; Edaki K; Nakazawa Y; Takahashi S; Sunakawa H; Mizoi K; Ogihara T
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation.
    Xiao G; Li Y; Wang M; Li X; Qin S; Sun X; Liang R; Zhang B; Du N; Xu C; Ren H; Liu D
    Cell Prolif; 2018 Oct; 51(5):e12473. PubMed ID: 30094882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of radixin knockdown on the expression and efflux function of MRP2 in SGC-7901 cells.
    He XJ; Wang WR; Zhang Y; Yang Q
    Eur J Pharm Sci; 2012 Aug; 46(5):426-34. PubMed ID: 22469515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro.
    Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L
    World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.
    Valinezhad Sani F; Mosaffa F; Jamialahmadi K; Palizban A
    Nutr Cancer; 2020; 72(3):522-527. PubMed ID: 31290701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel role of Snail 1 in promoting tumor neoangiogenesis.
    Zhang YK; Wang H; Guo YW; Yue Y
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
    Qu H; Fang L; Duan L; Long X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Studies of P-Glycoprotein and Its Expression Regulators.
    Yano K; Tomono T; Ogihara T
    Biol Pharm Bull; 2018; 41(1):11-19. PubMed ID: 29311472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism.
    Xu Q; Guo J; Chen W
    Biochem Biophys Res Commun; 2019 Jan; 508(3):882-888. PubMed ID: 30538042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
    Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC
    Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Thai plant extracts on P-glycoprotein function and viability in paclitaxel-resistant HepG2 cells.
    Kawami M; Yumoto R; Nagai J; Junyaprasert VB; Soonthornchareonnon N; Patanasethanont D; Sripanidkulchai BO; Takano M
    Drug Metab Pharmacokinet; 2010; 25(2):155-62. PubMed ID: 20460821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.